SCOTT M ROCKLAGE Insider Trading $APRE Aprea Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SCOTT M ROCKLAGE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SCOTT M ROCKLAGE. SCOTT M ROCKLAGE is Director in CUBIST PHARMACEUTICALS INC ($CBST) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in Pulmatrix, Inc. ($PULM) and Director in Cidara Therapeutics, Inc. ($CDTX) and in Aprea Therapeutics, Inc. ($APRE) and Director in Aprea Therapeutics, Inc. ($APRE).
SCOTT M ROCKLAGE in Aprea Therapeutics, Inc.
Trading Symbol: APREIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SCOTT M ROCKLAGE:
Holdings: 1,823,192 shares
Latest Transaction: Jul 01 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SCOTT M ROCKLAGE in Aprea Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APRE, CDTX, CBST, CRXX, PULM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 01 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | A | 38.78 | 5,600 | 217,168 | 5,600 | ||
Jun 18 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 33.30 | 4,807 | 160,073 | 75,965 | 80.8 K to 76 K (-5.95 %) |
Jun 18 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 33.30 | 115,357 | 3,841,388 | 1,823,192 | 1.9 M to 1.8 M (-5.95 %) |
Jun 15 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 28.75 | 9,800 | 281,776 | 80,772 | 90.6 K to 80.8 K (-10.82 %) |
Jun 15 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 28.75 | 235,200 | 6,762,635 | 1,938,549 | 2.2 M to 1.9 M (-10.82 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 10,200 | 358,530 | 90,572 | 100.8 K to 90.6 K (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 244,800 | 8,604,720 | 2,173,748 | 2.4 M to 2.2 M (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 10,200 | 358,530 | 90,572 | 100.8 K to 90.6 K (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 244,800 | 8,604,720 | 2,173,748 | 2.4 M to 2.2 M (-10.12 %) |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 20,519 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 20,519 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 492,475 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 492,475 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 79,746 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 79,746 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 1,913,910 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 1,913,910 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 20,519 | 0 | 100,772 | 80.3 K to 100.8 K (+25.57 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 20,519 | 0 | 100,772 | 80.3 K to 100.8 K (+25.57 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 492,475 | 0 | 2,418,548 | 1.9 M to 2.4 M (+25.57 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 492,475 | 0 | 2,418,548 | 1.9 M to 2.4 M (+25.57 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 79,746 | 0 | 80,253 | 507 to 80.3 K (+15,728.99 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 79,746 | 0 | 80,253 | 507 to 80.3 K (+15,728.99 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 1,913,910 | 0 | 1,926,073 | 12.2 K to 1.9 M (+15,735.51 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 1,913,910 | 0 | 1,926,073 | 12.2 K to 1.9 M (+15,735.51 %) |
Page: 1